Human immunodeficiency virus post-exposure prophylaxis: primum non nocere

Am J Med. 2015 Apr;128(4):e3-4. doi: 10.1016/j.amjmed.2014.10.060. Epub 2014 Dec 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / pharmacology
  • Bipolar Disorder / complications
  • Cytochrome P-450 CYP3A Inhibitors / administration & dosage
  • Cytochrome P-450 CYP3A Inhibitors / adverse effects*
  • Cytochrome P-450 CYP3A Inhibitors / pharmacology
  • Dihydroergotamine / administration & dosage
  • Dihydroergotamine / adverse effects*
  • Dihydroergotamine / blood
  • Drug Synergism
  • Drug Therapy, Combination
  • Ergotism / diagnosis
  • Ergotism / drug therapy
  • Ergotism / therapy*
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Hypotension, Orthostatic / complications
  • Hypotension, Orthostatic / drug therapy*
  • Lamivudine / administration & dosage
  • Lopinavir / administration & dosage
  • Post-Exposure Prophylaxis / methods*
  • Ritonavir / administration & dosage
  • Ritonavir / adverse effects
  • Ritonavir / pharmacology
  • Vasoconstrictor Agents / administration & dosage
  • Vasoconstrictor Agents / adverse effects*
  • Vasoconstrictor Agents / blood
  • Zidovudine / administration & dosage

Substances

  • Antiviral Agents
  • Cytochrome P-450 CYP3A Inhibitors
  • Vasoconstrictor Agents
  • Lopinavir
  • Lamivudine
  • Dihydroergotamine
  • Zidovudine
  • Ritonavir